High-volume haemofiltration for sepsis

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 1, 2013, Pages

  Borthwick, Emma M J ^a   Hill, Christopher J ^a   Rabindranath, Kannaiyan S ^b   Maxwell, Alexander P ^a   Mcauley, Danny F ^c   Blackwood, Bronagh ^d  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE EVENT; CLINICAL OUTCOME; COST BENEFIT ANALYSIS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; HEMODIALYSIS; HEMOFILTRATION; HIGH-VOLUME HEMOFILTRATION; HOSPITAL MORTALITY; HUMAN; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; LENGTH OF STAY; MORTALITY RATE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; QUASI EXPERIMENTAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPSIS; SYSTEMATIC REVIEW; CRITICAL ILLNESS; HEMODIAFILTRATION; METHODOLOGY; MORTALITY; SEPTIC SHOCK;

ADULT; CRITICAL ILLNESS; HEMODIAFILTRATION; HEMOFILTRATION; HUMANS; INTENSIVE CARE UNITS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEPSIS; SHOCK, SEPTIC;

MLCS; MLOWN;

EID: 84874795923     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD008075.pub2     Document Type: Review

References (45)

1. Boussekey N, Chiche A, Faure K, Devos P, Guery B, d'Escrivan T, et al.A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock. Intensive Care Medicine 2008;34:1646-53. [MEDLINE: 18542921]
2. Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P. High-volume haemofiltration in human septic shock. Intensive Care Medicine 2001;27(6):978-86. [MEDLINE: 11497156]
3. Ghani RA, Zainudin S, Ctkong N, Rahman AF, Wafa SR, Mohamad M, et al.Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration. Nephrology 2006;11(5):386-93. [MEDLINE: 17014550]
4. Abe M, Okada K, Suzuki M, Nagura C, Ishihara Y, Fujii Y, et al.Comparison of sustained hemodiafiltration with continuous venovenous hemodiafiltration for the treatment of critically ill patients with acute kidney injury. Artificial Organs April 2010;34(4):331-8. [MEDLINE: 20420616;: ]
5. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Goldsmith D, et al.Design and challenges of the Randomized Evaluation of Normal versus Augmented Level Replacement Therapy (Renal) Trial: high-dose versus standard-dose hemofiltration in acute renal failure. Blood Purification 2008;26:407-16. [MEDLINE: 18856012;: ]
6. Bouman CSC, Oudemans-van Straaten HM, Tijssen JGP, Zandstra DF, Kesecioglu J. Effects of early high-volume continuous venovenous hemofiltrationon survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Critical Care Medicine 2002;30(10):2205-11. [MEDLINE: 1239494]
7. Bouman CSC, Straaten HMO, Schultz MJ, Vroom MB. Hemofiltration in sepsis and systemic inflammatory response syndrome: the role of dosing and timing. Journal of Critical Care 2007;22(1):1-12. [MEDLINE: 17371737]
8. Castro R, Regueira T, Aguirre ML, Llanos OP, Bruhn A, Bugedo G, et al.An evidence-based resuscitation algorithm applied from the emergency room to the ICU improves survival of severe septic shock. Minerva Anestesiologica 2008;74(6):223-31. [MEDLINE: 18356807]
9. Cole L, Bellomo R, Baldwin I, Hayhoe M, Ronco C. The impact of lactate-buffered high-volume hemofiltration on acid-base balance. Intensive Care Medicine. 2003;29(7):1113-20. [MEDLINE: 12783161]
10. Haase M, Silvester W, Uchino S, Goldsmith D, Davenport P, Tipping P, et al.A pilot study of high-adsorption hemofiltration in human septic shock. International Journal of Artificial Organs 2007;30(2):108-17. [MEDLINE: 17377905]
11. Hoffmann JN, Hartl WH, Deppisch R, Faist E, Jochum M, Inthorn D. Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Medicine 1996;22:1360-7. [MEDLINE: 8986487]
12. Honore PM, Zydney A, Matson JR. High volume and high permeability haemofiltration for sepsis: the evidence and the key issues. Care of the Critically Ill 2003;19(3):69.
13. Honore PM, Joannes-Boyau O. High volume hemofiltration (Hvhf) in sepsis: a comprehensive review of rationale, clinical applicability, potential Indications and recommendations for future research. International Journal of Artificial Organs 2004;27(12):1077-82. [MEDLINE: 15645619]
14. Honore PM, Joannes-Boyau O, Gressens B. Blood and plasma treatments: high-volume hemofiltration--a global view. Contributions to Nephrology 2007;156:371-86. [MEDLINE: 17464148]
15. Honore PM, Joannes-Boyau O, Boer W, Collin V. High-volume hemofiltration in sepsis and SIRS: current concepts and future prospects. Blood Purification 2009;28(1):1-11. [MEDLINE: 19325233]
16. Mao HJ, Yu S, Yu XB, Zhang B, Zhang L, Xu XR. Effects of coupled plasma filtration adsorption on immune function of patients with multiple organ dysfunction syndrome. The International Journal of Artificial Organs 2009;32(1):31-8. [MEDLINE: 19241361]
17. Morgera S, Haase M, Kuss T, Vargas-Hein O, Zuckermann-Becker H, Melzer C, et al.Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure. Critical Care Medicine 2006;34(8):2099-104. [MEDLINE: 16763508]
18. Oudemans-van Straaten HM, Bosman RJ, van der Spoel JI, Zandstra DF. Outcome of critically ill patients treated with intermittent high-volume haemofiltration: a prospective cohort analysis. Intensive Care Medicine 1999;25(8):814-21. [MEDLINE: 10447538]
19. VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang, JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, et al.Intensity of renal support in critically ill patients with acute kidney injury. New England Journal of Medicine 2008;359(1):7-20. [MEDLINE: 18492867]
20. Payen D, Mateo J, Cavaillon JM, Fraisse F, Floriot C, Vicaut E and Hemofiltration and Sepsis Group of the Collège National de Réanimation et de Médecine d'Urgence des Hôpitaux extra-Universitaires. Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial. Critical Care Medicine 2009;37(3):803-10. [MEDLINE: 19237881]
21. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, et al.Effects of different doses in continuous veno-venous haemofiltrationon outcomes of acute renal failure: a prospective randomised trial. Lancet 2000;355:26-30. [MEDLINE: 10892761]
22. Storck M, Hartl WH, Zimmerer E, Inthorn D. Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure. Lancet 1991;337:452-5. [MEDLINE: 1671471]
23. Yu C, Liu ZH, Chen ZH, Gong DH, Ji DX, Li LSH. Improvement of monocyte function and immune homeostasis by high volume continuous venovenous hemofiltration in patients with severe acute pancreatitis. International Journal of Artificial Organs 2008;31(10):882-90. [MEDLINE: 19009506]
24. Zainudin S, Ghani RA, Mohd M, Wafa SRW, Tong NKC. Stability of haemodynamic parameters during CRRT: a comparison between standard continuous venovenous haemofiltration and high-volume haemofiltration in patients with acute renal failure and sepsis [abstract no: SP286]. Nephrology Dialysis Transplantation 2006;21[Suppl 4]:iv108.
25. Han SS, Sun T, Li Z, Jia LZ, Shang QM, Wang XZ. Effect of continuous blood purification on endothelial cell function in patients with severe sepsis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue/ Chinese Critical Care Medicine 2011;23(2):81-4. [MEDLINE: 21315003]
26. Wang CT, Ren HS, Jiang JJ, Zhang JC, Meng M, Yu JB, et al.Study the effects of high-volume hemofiltration and fluid resuscitation on removing blood lactic acid and pro-inflammatory cytokines in patients with refractory septic shock [Chinese] [Zhongguo Wei Zhong Bing Ji Jiu Yi Xue]. Chinese Critical Care Medicine 2009;21(7):421-4. [MEDLINE: 19615135]
27. Xie J, Yang J. Effect of continuous high-volume hemofiltration on patients with acute respiratory distress syndrome and multiple organ dysfunction syndrome. Chinese Critical Care Medicine 2009;21(7):402-4. [MEDLINE: 19615130]
28. Zhang J, Tao LJ, Ning JP, Xu H, Ai YH, Zhao SP. Effects of high-volume hemofiltration on serum levels of tumor necrosis factor and its receptors in patients with multiple organ dysfunction syndromes. Chinese Critical Care Medicine 2004;16(2):81-4. [MEDLINE: 14764220]
29. Zhang P, Peng P, Wang HM, Zhu J, Liu HB, Li, R, et al.Evaluation of the effects of pulse high-volume hemofiltration in patients with severe sepsis: a preliminary study. International Journal of Artificial Organs 2010;33(8):505-11. [MEDLINE: 20872345]
30. Abraham E, Matthay MA, Dinarello CA, Vincent JL, Cohen J, Opal SM, et al.Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Critical Care Medicine 2000;28(1):232-5. [MEDLINE: 10667529]
31. Adrie C, Pinsky MR. The inflammatory balance in human sepsis. Intensive Care Medicine 2000;26(4):364-75. [MEDLINE: 10872127]
32. Alejandria MM, Lansang MAD, Dans LF, Mantaring III JB. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. Cochrane Database of Systematic Reviews 2010, Issue 2. [DOI: 10.1002/14651858.CD001090]
33. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky M. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Critical Care Medicine 2001;29(7):1303-10. [PUBMED: 11445675 ]
34. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y. Corticosteroids for treating severe sepsis and septic shock. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD002243.pub2]
35. De Vriese AS, Colardyn FA, Philippe JJ, Vanholder RC, de Sutter JH, Lamiere NH. Cytokine removal during continuous hemofiltration in septic patients. Journal of the American Society of Nephrology 1999;10:846-53. [PUBMED: 10203370]
36. Gomes Silva BN, Andriolo RB, Atallah ÁN, Salomão R. De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. Cochrane Database of Systematic Reviews 2010, Issue 12. [DOI: 10.1002/14651858.CD007934.pub2]
37. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
38. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. New England Journal of Medicine 2003;348(2):138-50. [PUBMED: 12519925]
39. Joannidis M. Continuous renal replacement therapy in sepsis and multisystem organ failure. Seminars in Dialysis. 2009;22(2):160-4. [MEDLINE: 19426421]
40. Martí-Carvajal AJ, Solà I, Lathyris D, Cardona AF. Human recombinant activated protein C for severe sepsis. Cochrane Database of Systematic Reviews 2011, Issue 4. [DOI: 10.1002/14651858.CD004388.pub4]
41. Reiter K, Bellomo R, Ronco C, Kellum JA. Pro/con clinical debate: Is high-volume hemofiltration beneficial in the treatment of septic shock?. Critical Care 2002;6(1):18-21. [PUBMED: 11940261 ]
42. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Review Manager (RevMan): The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
43. Ronco C, Ricci Z, Bellomo R. Importance of increased ultrafiltration volume and impact on mortality: sepsis and cytokine story and the role of continuous veno-venous haemofiltration. Current Opinions in Nephrology and Hypertension 2001;10:755-61. [PUBMED: 11706302]
44. Ronco C, Inguaggiato P, D'Intini V, Cole L, Bellomo R, Poulin S, et al.The role of extracorporeal therapies in sepsis. International Journal of Nephrology 2003;16(Suppl 7):S34-41. [MEDLINE: 14733299]
45. The Surviving Sepsis Campaign. www.survivingsepsis.org (accessed 5th November 2008).